CORC

在结果中检索

CORC

浏览/检索结果: 共19条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:  Zhao, Wan-Hong;  Liu, Jie;  Wang, Bai-Yan;  Chen, Yin-Xia;  Cao, Xing-Mei
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: a meta-analysis 期刊论文
BMC CANCER, 2018, 卷号: Vol.18
作者:  Zhou, Hui;  Luo, Yuling;  Zhu, Sha;  Wang, Xi;  Zhao, Yunuo
收藏  |  浏览/下载：9/0  |  提交时间：2019/02/28
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia. 期刊论文
International journal of hematologic oncology, 2018, 卷号: No.2, 页码: IJH06
作者:  Ma Jun;  Liu Ting;  Jin Jie;  Hu Jianda;  Liu Qifa
收藏  |  浏览/下载：6/0  |  提交时间：2019/02/28
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10
作者:  Luo, Xian-Wu;  Du, Xue-Qing;  Li, Jie-Li;  Liu, Xiao-Ping;  Meng, Xiang-Yu
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia 期刊论文
2018, 卷号: 7, 期号: 2, 页码: IJH06
作者:  Ma Jun;  Liu Ting;  Jin Jie;  Hu Jianda;  Liu Qifa
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus 期刊论文
2018, 卷号: 97, 期号: 11, 页码: 2047-2054
作者:  Long, Zhangbiao;  Yu, Fan;  Du, Yali;  Li, Hongmin;  Chen, Miao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study 期刊论文
Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 137
作者:  Hou, Jian*;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/03
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study 期刊论文
2017, 卷号: 10, 期号: 1, 页码: 137
作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04
Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review 期刊论文
2017, 卷号: 17, 页码: 87-91
作者:  Xue Jingwen;  Liu Cynthia;  Liu Yuehua
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma 期刊论文
Chinese Journal of Cancer, 2016, 卷号: 第35卷, 页码: P699-705
作者:  Leng Yun;  Qiu Lugui;  Hou Jian;  Zhao Yaozhong;  Zhang Xuejun
收藏  |  浏览/下载：7/0  |  提交时间：2019/02/28

©版权所有 ©2017 CSpace - Powered by CSpace